Surmodics Operating Margin 2010-2025 | SRDX
Current and historical operating margin for Surmodics (SRDX) over the last 10 years. The current operating profit margin for Surmodics as of June 30, 2025 is -2.84%.
| Surmodics Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-06-30 | $0.12B | $-0.01B | -9.92% |
| 2025-03-31 | $0.12B | $-0.01B | -9.92% |
| 2024-12-31 | $0.13B | $-0.01B | -5.60% |
| 2024-09-30 | $0.13B | $-0.01B | -3.97% |
| 2024-06-30 | $0.12B | $-0.01B | -4.96% |
| 2024-03-31 | $0.14B | $0.02B | 13.99% |
| 2023-12-31 | $0.14B | $0.01B | 8.70% |
| 2023-09-30 | $0.13B | $0.01B | 3.79% |
| 2023-06-30 | $0.13B | 0 | 0.00% |
| 2023-03-31 | $0.10B | $-0.03B | -27.18% |
| 2022-12-31 | $0.10B | $-0.03B | -25.49% |
| 2022-09-30 | $0.10B | $-0.02B | -22.00% |
| 2022-06-30 | $0.10B | $-0.02B | -15.31% |
| 2022-03-31 | $0.10B | $-0.01B | -10.31% |
| 2021-12-31 | $0.11B | $0.00B | 3.77% |
| 2021-09-30 | $0.11B | $0.01B | 6.67% |
| 2021-06-30 | $0.10B | $0.01B | 4.81% |
| 2021-03-31 | $0.11B | $0.01B | 7.48% |
| 2020-12-31 | $0.10B | $0.00B | -1.05% |
| 2020-09-30 | $0.10B | $0.00B | -1.04% |
| 2020-06-30 | $0.10B | $0.01B | 4.81% |
| 2020-03-31 | $0.10B | $0.01B | 4.95% |
| 2019-12-31 | $0.10B | $0.01B | 5.94% |
| 2019-09-30 | $0.10B | $0.01B | 7.00% |
| 2019-06-30 | $0.09B | $0.00B | 1.09% |
| 2019-03-31 | $0.09B | $-0.01B | -6.67% |
| 2018-12-31 | $0.09B | $-0.01B | -6.98% |
| 2018-09-30 | $0.08B | $-0.01B | -9.88% |
| 2018-06-30 | $0.08B | $-0.01B | -7.69% |
| 2018-03-31 | $0.07B | $0.00B | 2.70% |
| 2017-12-31 | $0.07B | $0.00B | 4.11% |
| 2017-09-30 | $0.07B | $0.01B | 9.46% |
| 2017-06-30 | $0.07B | $0.01B | 15.28% |
| 2017-03-31 | $0.07B | $0.02B | 21.62% |
| 2016-12-31 | $0.07B | $0.02B | 21.92% |
| 2016-09-30 | $0.07B | $0.02B | 23.61% |
| 2016-06-30 | $0.07B | $0.02B | 23.94% |
| 2016-03-31 | $0.07B | $0.02B | 23.88% |
| 2015-12-31 | $0.06B | $0.02B | 28.13% |
| 2015-09-30 | $0.06B | $0.02B | 31.15% |
| 2015-06-30 | $0.06B | $0.02B | 33.90% |
| 2015-03-31 | $0.06B | $0.02B | 32.76% |
| 2014-12-31 | $0.06B | $0.02B | 31.03% |
| 2014-09-30 | $0.06B | $0.02B | 29.31% |
| 2014-06-30 | $0.06B | $0.02B | 31.58% |
| 2014-03-31 | $0.06B | $0.02B | 30.36% |
| 2013-12-31 | $0.06B | $0.02B | 32.14% |
| 2013-09-30 | $0.06B | $0.02B | 33.93% |
| 2013-06-30 | $0.06B | $0.02B | 32.14% |
| 2013-03-31 | $0.06B | $0.02B | 33.93% |
| 2012-12-31 | $0.05B | $0.02B | 35.19% |
| 2012-09-30 | $0.05B | $0.02B | 32.69% |
| 2012-06-30 | $0.05B | $0.02B | 28.85% |
| 2012-03-31 | $0.05B | $0.01B | 27.45% |
| 2011-12-31 | $0.05B | $0.01B | 26.92% |
| 2011-09-30 | $0.05B | $0.02B | 28.30% |
| 2011-06-30 | $0.06B | $-0.01B | -10.91% |
| 2011-03-31 | $0.06B | $-0.01B | -13.11% |
| 2010-12-31 | $0.07B | $-0.01B | -19.70% |
| 2010-09-30 | $0.07B | $-0.01B | -20.00% |
| 2010-06-30 | $0.07B | $0.01B | 10.96% |
| 2010-03-31 | $0.07B | $0.01B | 15.28% |
| 2009-12-31 | $0.08B | $0.02B | 24.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.527B | $0.126B |
| Surmodics is a leading provider of medical device and In Vitro Diagnostics (IVD) technologies to the healthcare industry. It reports through two divisions: Medical Devices & IVD.?The Medical Devices segment comprises surface modification coating technologies to improve access, deliverability, and predictable deployment of medical devices, international cardiology and peripheral balloon design, development and manufacturing, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device, with end markets that include coronary, peripheral, neuro-vascular and urology, among others. The IVD segment includes component products and technologies for diagnostic test kits and biomedical research applications, with products that include protein stabilization reagents, substrates, antigens and surface coatings. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $226.730B | 26.59 |
| Boston Scientific (BSX) | United States | $152.695B | 36.41 |
| Stryker (SYK) | United States | $145.892B | 29.70 |
| EssilorLuxottica (ESLOY) | France | $145.168B | 0.00 |
| Medtronic (MDT) | Ireland | $118.964B | 16.88 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.349B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.447B | 24.82 |
| ResMed (RMD) | United States | $41.892B | 29.96 |
| Agilent Technologies (A) | United States | $33.562B | 21.88 |
| GE HealthCare Technologies (GEHC) | United States | $33.407B | 15.70 |
| Terumo (TRUMY) | Japan | $27.938B | 33.10 |
| Koninklijke Philips (PHG) | Netherlands | $26.432B | 17.48 |
| Insulet (PODD) | United States | $22.742B | 76.20 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.317B | 12.93 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.894B | 0.00 |
| Baxter (BAX) | United States | $12.127B | 9.37 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.703B | 28.30 |
| Lantheus Holdings (LNTH) | United States | $3.806B | 10.29 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.452B | 24.15 |
| Prestige Consumer Healthcare (PBH) | United States | $3.193B | 14.16 |
| Perrigo (PRGO) | Ireland | $3.169B | 7.91 |
| ICU Medical (ICUI) | United States | $3.035B | 20.67 |
| Haemonetics (HAE) | United States | $2.559B | 11.42 |
| LeMaitre Vascular (LMAT) | United States | $2.151B | 46.14 |
| Curaleaf Holdings (CURLF) | Canada | $1.944B | 0.00 |
| AtriCure (ATRC) | United States | $1.770B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.753B | 11.03 |
| Green Thumb Industries (GTBIF) | United States | $1.751B | 75.18 |
| AdaptHealth (AHCO) | United States | $1.269B | 18.04 |
| Phibro Animal Health (PAHC) | United States | $1.267B | 16.19 |
| Tilray Brands (TLRY) | Canada | $1.255B | 0.00 |
| Neogen (NEOG) | United States | $1.203B | 19.10 |
| Acuren (TIC) | United States | $1.182B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.174B | 2450.00 |
| Valneva SE (VALN) | France | $1.033B | 0.00 |
| InMode (INMD) | Israel | $0.904B | 8.37 |
| Kestra Medical Technologies (KMTS) | United States | $0.826B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.654B | 0.00 |
| SNDL (SNDL) | Canada | $0.568B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.557B | 0.00 |
| ZimVie (ZIMV) | United States | $0.534B | 20.60 |
| Verano Holdings (VRNOF) | United States | $0.506B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.458B | 15.76 |
| CeriBell (CBLL) | United States | $0.447B | 0.00 |
| Evolus (EOLS) | United States | $0.433B | 0.00 |
| Owens & Minor (OMI) | United States | $0.421B | 3.73 |
| Capricor Therapeutics (CAPR) | United States | $0.352B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.329B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.329B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.298B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.289B | 0.00 |
| Omeros (OMER) | United States | $0.288B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.281B | 0.00 |
| Brainsway (BWAY) | Israel | $0.281B | 57.12 |
| Viemed Healthcare (VMD) | United States | $0.268B | 20.35 |
| Vireo Growth (VREOF) | United States | $0.244B | 0.00 |
| High Tide (HITI) | Canada | $0.242B | 0.00 |
| Cerus (CERS) | United States | $0.240B | 0.00 |
| Quanterix (QTRX) | United States | $0.230B | 0.00 |
| Exagen (XGN) | United States | $0.215B | 0.00 |
| Organigram Global (OGI) | Canada | $0.205B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.205B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.184B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.183B | 15.28 |
| FitLife Brands (FTLF) | United States | $0.157B | 19.36 |
| Biote (BTMD) | United States | $0.149B | 4.95 |
| Jushi Holdings (JUSHF) | United States | $0.121B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.098B | 0.00 |
| MacroGenics (MGNX) | United States | $0.096B | 0.00 |
| Jin Medical (ZJYL) | China | $0.095B | 0.00 |
| Fonar (FONR) | United States | $0.094B | 12.07 |
| Safety Shot (SHOT) | United States | $0.088B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.085B | 0.00 |
| Apyx Medical (APYX) | United States | $0.081B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.069B | 0.00 |
| Agape ATP (ATPC) | $0.066B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.055B | 32.16 |
| Veru (VERU) | United States | $0.051B | 0.00 |
| Zynex (ZYXI) | United States | $0.046B | 0.00 |
| Nephros (NEPH) | United States | $0.046B | 35.83 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 13.95 |
| Trinity Biotech (TRIB) | Ireland | $0.028B | 0.00 |
| Senestech (SNES) | United States | $0.024B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |